ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MAR Maravai LifeSciences Holdings Inc

5.60
-0.05 (-0.88%)
29 Nov 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Maravai LifeSciences Holdings Inc TG:MAR Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -0.88% 5.60 5.40 5.55 5.60 5.60 5.60 200 20:41:17

MARKET SNAPSHOT: Stock Investors Eye Revenues As Earnings Kick Off

05/10/2009 7:25pm

Dow Jones News


Maravai LifeSciences (TG:MAR)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Maravai LifeSciences Charts.

By Nick Godt

With the third-quarter earnings season just about to kick off, the market is looking to some sectors, such as financials, where revenue growth might actually improve.

In the previous quarter, investors were satisfied with seeing improvement in firms' net income, the so-called bottom line, which was mostly the result of heavy cost-cutting to adapt to a slumping global economy.

"Companies have undergone a fantastic run of cost-cutting which will surely benefit the bottom line to a larger than normal degree when top-line growth returns," said Dan Greenhaus, chief economist strategist at Miller Tabak, in a note.

"Given the improvement in the economy as well as the equity market, perhaps a wealth-effect flow-through, this could very well be the quarter in which revenue growth returns," he said.

Financials, which suffered the brunt of the credit crisis of the past two years, might be among the sectors where surprises start to emerge.

On Monday, Goldman Sachs upgraded its view of large banks, highlighting an improvement in Wells Fargo's (WFC) capital position as well as its takeover of Wachovia. Goldman also added Capital One (COF) to its conviction buy list, saying it expects a positive revenue surprise from the bank, citing moderating consumer credit problems.

The financials sector, freed from the write-downs that crippled results last year, is expected to be the best performer this quarter, with earnings on average expected to be up by 59% from the year earlier, according to Thomson Reuters.

On Monday, the Dow Jones Industrial Average (DJI) gained 90 points, or 1%, to 9,577. The S&P 500 index (SPX) rose 12 points, or 1.2%, to 1,037, while the Nasdaq Composite (RIXF) added 18 points, or 1%, to 2,066.

Greenhaus also takes heart from the big 2.7% surge in U.S. retail sales in August. While the government's cash-for-clunkers largely helped boost autos sales at the likes of Ford Motor Co. (F), sales ex-autos also rose a hefty 1.1%.

Sales at clothing stores, department stores, sporting-goods stores, and book stores were up more than 2%, and electronics retailers also saw 1.1% increase.

"We don't have the September sales yet, but based on [August] perhaps the consumer discretionary sector did better [this quarter]," Greenhaus said. "It's tough to predict a consumer-based recovery, which is the main determinant of top-line growth."

Among consumer-discretionary firms slated to report this week are Yum Brands Inc. (YUM) on Tuesday as well as Costco Wholesale Corp. (COST) and Family Dollar Stores Inc. (FDO) on Wednesday, while Marriott International (MAR) and PepsiCo (PEP) are due to issue their results on Thursday.

Earnings in the consumer-discretionary sector of the S&P 500 are expected are expected to be up by 17% year on year, according to Thomson.

The overseas play

The market slumped last week as concerns about the U.S. economy resurfaced after several weak economic reports, especially a worse-than-expected September jobs survey.

Now, "it all boils down to earnings," said Ed Yardeni, chief investment strategist at Yardeni Research, in written comments. "Can they recover even if employment remains weak?"

Yardeni answers in the affirmative. "U.S. companies are scrambling to decouple from the U.S. economy, and are finding more revenues and earnings overseas, especially among emerging economies," he said.

Further, "even a subpar recovery in domestic revenues could morph into significant earnings growth given all the cost cutting that has been going on during the recession," Yardeni said.

Speaking with portfolio managers, Yardeni said he found them to leaning toward information technology as one of the best plays of the global recovery, especially if that recovery is helped by rising incomes for the consumers in emerging economies who'd tend to buy cell phones, laptops, and other electronics items.

The tech sector could provide some upbeat surprises, says Owen Fitzpatrick, head of U.S. equities at Deutsche Bank. Overall earnings in the information-technology sector are expected to be down 15% in the third quarter from the year earlier quarter.

"I expect this earnings season to be like previous quarters, with companies beating expectations," Fitzpatrick said. "But now we do want to see more visibility and some improvements in [revenue], not just the bottom line."

 
 

1 Year Maravai LifeSciences Chart

1 Year Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

Your Recent History

Delayed Upgrade Clock